RLN2 and coronary artery disorder: Interestingly, these studies bring up the question of whether relaxin-2, in addition to its ability as a preventative drug that induces cardioprotection during I/R injury, could also be considered a useful biomarker for the prevention and diagnosis in advance of ischemic heart disease.